title: Comparison of 3% sorbitol vs psyllium fibre as oral contrast agents in MR enterography.
abstract: To compare the degree of small bowel distension achieved by 3% sorbitol, a high osmolarity solution, and a psyllium-based bulk fibre as oral contrast agents (OCAs) in MR enterography (MRE).
  
  
  
  This retrospective study was approved by our institutional review board. A total of 45 consecutive normal MRE examinations (sorbitol, n = 20; psyllium, n = 25) were reviewed. The patients received either 1.5 l of 3% sorbitol or 2 l of 1.6 g kg(-1) psyllium prior to imaging. Quantitative small bowel distension measurements were taken in five segments: proximal jejunum, distal jejunum, proximal ileum, distal ileum and terminal ileum by two independent radiologists. Distension in these five segments was also qualitatively graded from 0 (very poor) to 4 (excellent) by two additional independent radiologists. Statistical analysis comparing the groups and assessing agreement included intraclass coefficients, Student's t-test and Mann-Whitney U-test.
  
  
  
  Small bowel distension was not significantly different in any of the five small bowel segments between the use of sorbitol and psyllium as OCAs in both the qualitative (p = 0.338-0.908) and quantitative assessments (p = 0.083-0.856). The mean bowel distension achieved was 20.1 ± 2.2 mm for sorbitol and 19.8 ± 2.5 mm for psyllium (p = 0.722). Visualization of the ileum was good or excellent in 65% of the examinations in both groups.
  
  
  
  Sorbitol and psyllium are not significantly different at distending the small bowel and both may be used as OCAs for MRE studies.
  
  
  
  This is the first study to directly compare the degree of distension in MRE between these two common, readily available and inexpensive OCAs.
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Sidharth
authors: S
authors: Saini
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Errol
authors: E
authors: Colak
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Shalini
authors: S
authors: Anthwal
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Paraskevi A
authors: PA
authors: Vlachou
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Antony
authors: A
authors: Raikhlin
authors: Department of Medical Imaging, St Michael's Hospital and University of Toronto, Toronto, ON, Canada.
authors: Anish
authors: A
authors: Kirpalani
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007421:Intestine, Small / Q000187:drug effects*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011134:Polysaccharides; D011620:Psyllium / Q000008:administration & dosage; D012189:Retrospective Studies; D013012:Sorbitol / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D003287:Contrast Media; D011134:Polysaccharides; D013012:Sorbitol; D011620:Psyllium